Portfolio projects & companies

MIVAC Development works with projects within the field of "mucosal immunobiology and vaccine development", with a particular interest for treatments of autoimmune diseases.

As of today, three different projects, all originating from MIVAC center-of-excellence at University of Gothenburg, have undergone verification within MIVAC Development. Two of these ideas have been spun-out into separate companies, Alzinova and Toleranzia.

MIVAC Development is now interested in expanding the portfolio with new project ideas within our focus area, please contact us if you would like to present a project to us.